Clinical Trials Logo

Filter by:
NCT ID: NCT05767333 Completed - Skin Diseases Clinical Trials

Evaluation of Cicaplast in Subjects With Skin Irritation

Start date: October 11, 2021
Phase:
Study type: Observational

The aim of this open, before/after, multicentric study is to assess the effect and tolerance of Cicaplast Baume B5 in patients having a skin irritation (irritative and cracked dermatitis, dry eczematids, rubbing irritation, ...) under dermatological control. Patients are asked to apply the product at least twice a day until complete recovery (maximum 21 days).

NCT ID: NCT05764265 Completed - Clinical trials for Pulmonary Arterial Hypertension

Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

Start date: March 27, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to measure the long-term safety and efficacy profile of LTP001 in participants with pulmonary arterial hypertension (PAH). The study offers participants who had completed the CLTP001A12201 double-blind parent study in PAH an opportunity to receive LTP001 (whether they were on LTP001 or not). Unblinding of the treatment received in CLTP001A12201 is generally not needed, but can occur on request by the investigator.

NCT ID: NCT05763108 Completed - Clinical trials for Recurrent Patellar Dislocation

Clinical Significance and Coexistence of Polymorphisms of Individual Collagen-coding Genes

Start date: April 1, 2022
Phase:
Study type: Observational

The purpose of this study is to assess correlation between recurrent patella dislocation and genetic polymorphism rs1800012 of the COL1A1 Gene and rs12722 of the COL5A1 Gene.

NCT ID: NCT05762939 Completed - Depression Clinical Trials

Chatbot Intervention for Anxiety and Depressive Symptoms in Young Adults

Start date: May 3, 2022
Phase: N/A
Study type: Interventional

This clinical trial compares the effects of using an artificial intelligence based therapy chatbot and a self-help book to lower anxiety and depressive symptoms. The therapy chatbot (named Fido) is an application delivering support for mental health via a conversation-like interface in a highly inflected language (Polish). The team will recruit young people (aged 18-35) who currently struggle with anxiety and/or depression. The participants will use the chatbot or self-help materials for two weeks. Then, the researchers will check if using the chatbot or the book improved several aspects of mental health and the quality of life. Moreover, they will compare the groups for any differences in outcomes.

NCT ID: NCT05757518 Completed - Injury;Sports Clinical Trials

Post-exercise Recovery of DOMS in Recreational Athletes

Start date: January 16, 2023
Phase: N/A
Study type: Interventional

The main goal of this study was to investigate the effectiveness of cryo-sauna in preventing the development of DOMS in the lower extremity. The second goal is to analyze the rate of regenerative changes in the right muscles after acute fatigue-induced exercises.

NCT ID: NCT05750303 Completed - Ischemic Stroke Clinical Trials

Potential Prognostic Markers of Recovery in Post-stroke Rehabilitation

Start date: January 2, 2022
Phase:
Study type: Observational

Despite increasingly effective early treatment strategies for ischemic stroke, post-stroke recovery is often incomplete and depend on spontaneous and therapeutic-induced processes related to neuroplasticity, angiogenesis and reperfusion. These processes are regulated by growth factors, neurotrophines, neurotransmitters, hormones and other factors. This study aims to search biomarkers that prognose brain repair ability and consequently estimate an outcome of stroke patients. The prognostic value of proteins VEGF, IGF-1 and MMP-9 and expression of genes VEGF, IGF-1, MMP-9 is evaluated in association with clinical scales including cognitive assessment scales and depression scales. Blood sample collection as well as scales recording are taken at baseline and 3 weeks later after rehabilitation.

NCT ID: NCT05740826 Completed - Clinical trials for Temporomandibular Joint Disorders

Correlation Between Cervical Spine Muscle Disorders and the Occurrence of Symptoms of Temporomandibular Joint Dysfunction

Start date: September 8, 2022
Phase:
Study type: Observational

This study evaluated the correlation between the occurrence of disorders of selected muscles of the cervical spine and the occurrence of symptoms of TMJ dysfunction

NCT ID: NCT05739604 Completed - Sepsis Clinical Trials

Serum Free Amino Acid Concentrations in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy (CRRT)

Start date: June 19, 2020
Phase:
Study type: Observational

Sepsis is a life-threatening condition associated with high morbidity and mortality. The breakdown of proteins mainly from skeletal muscles leads to the release of free amino acids (FAAs). The serum FAA pool has been repeatedly assessed and found to be significantly altered in patients with sepsis/septic shock. Sepsis is well known to be the most common factor contributing to the development of acute kidney injury in critically ill patients. The investigators want to establish the baseline profile of FAAs and their derivatives in patients with sepsis/septic shock undergoing continuous renal replacement therapy due to sepsis-associated acute kidney injury. Secondly, the investigators want to compare the FAA profiles of the survivors and nonsurvivors.

NCT ID: NCT05732337 Completed - Chickenpox Clinical Trials

Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.

Start date: January 30, 2023
Phase: N/A
Study type: Interventional

The primary endpoint is the change of the itching score after 3 days of the product use in comparison to the basal value.

NCT ID: NCT05731232 Completed - Clinical trials for Irritable Bowel Syndrome

Effects of Vivatlac Synbiotikum in Patients With Irritable Bowel Syndrome

ViIBS
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

Multi-centre, randomized, double-blind, placebo-controlled trial investigating the effects of a nine-strain synbiotic (Vivatlac Synbiotikum) in IBS patients.